Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast

Kim T, Jung E A, Song J Y, Roh J H, Choi J S, Kwon J E, Kang S Y, Cho E Y, Shin J H, Nam S‐J, Yang J H & Choi Y‐L 
(2012) Histopathology 60, 347–356 
Prevalence of the CTNNB1 mutation genotype in surgically resected fibromatosis of the breast

[1]  I. Ellis,et al.  β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast , 2010, Modern Pathology.

[2]  N. McLean,et al.  Desmoid tumour of the breast. , 2010, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[3]  A. Lazar,et al.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. , 2008, The American journal of pathology.

[4]  T. Giordano,et al.  Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast , 2008, Clinical Cancer Research.

[5]  A. H. Lee Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast , 2007, Histopathology.

[6]  D. Kimelman,et al.  Mechanistic insights from structural studies of β-catenin and its binding partners , 2007, Journal of Cell Science.

[7]  P. Pauwels,et al.  Detection of β-Catenin Mutations in Paraffin-embedded Sporadic Desmoid-type Fibromatosis by Mutation-specific Restriction Enzyme Digestion (MSRED): an Ancillary Diagnostic Tool , 2007, The American journal of surgical pathology.

[8]  M. Ballo,et al.  Optimizing treatment of desmoid tumors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P. Polakis The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.

[10]  E. Brogi,et al.  Desmoid Tumors (Fibromatoses) of the Breast: A 25-Year Experience , 2007, Annals of Surgical Oncology.

[11]  K. Jones,et al.  Wnt signaling: is the party in the nucleus? , 2006, Genes & development.

[12]  L. Fellah,et al.  Dynamic breast MRI in recurrent fibromatosis. , 2005, AJR. American journal of roentgenology.

[13]  T. Nakazono,et al.  Dynamic MRI of fibromatosis of the breast. , 2003, AJR. American journal of roentgenology.

[14]  L. Mariani,et al.  Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Krasinskas,et al.  Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. , 2002, Human pathology.

[16]  A. Krasinskas,et al.  Fibromatosis of the breast and mutations involving the APC/β-catenin pathway , 2002 .

[17]  M. Devouassoux‐Shisheboran,et al.  Fibromatosis of the breast: age-correlated morphofunctional features of 33 cases. , 2000, Archives of pathology & laboratory medicine.

[18]  M. Ballo,et al.  Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  R. T. Tjon a Tham,et al.  Magnetic resonance imaging findings in aggressive fibromatosis. , 1993, European journal of radiology.

[20]  M. Kossoff,et al.  Sonographic features of fibromatosis of the breast. , 1991, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  P. Rosen,et al.  Mammary fibromatosis. A benign spindle‐cell tumor with significant risk for local recurrence , 1989, Cancer.

[22]  R. M. Austin,et al.  Fibromatosis of the Breast : A Clinical and Pathological Study of 28 Cases , 1987, The American journal of surgical pathology.

[23]  B. Gardner,et al.  Fibromatosis of the breast , 1978, Cancer.